Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.58 USD | +0.26% | -2.05% | +11.63% |
Apr. 23 | Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
Apr. 23 | Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024 |
Financials (USD)
Sales 2024 * | 389M | Sales 2025 * | 536M | Capitalization | 1.39B |
---|---|---|---|---|---|
Net income 2024 * | -7M | Net income 2025 * | 42M | EV / Sales 2024 * | 2.95 x |
Net cash position 2024 * | 242M | Net cash position 2025 * | 386M | EV / Sales 2025 * | 1.87 x |
P/E ratio 2024 * |
-184
x | P/E ratio 2025 * |
33.5
x | Employees | 297 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.42% |
Latest transcript on Kiniksa Pharmaceuticals, Ltd.
1 day | +0.26% | ||
1 week | -2.05% | ||
Current month | +4.59% | ||
1 month | +13.24% | ||
3 months | -1.41% | ||
6 months | +28.82% | ||
Current year | +11.63% |
Managers | Title | Age | Since |
---|---|---|---|
Eben Tessari
FOU | Founder | 42 | 15-06-30 |
Sanj Patel
CEO | Chief Executive Officer | 54 | 15-06-30 |
Mark Ragosa
DFI | Director of Finance/CFO | 50 | 18-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Felix Baker
BRD | Director/Board Member | 55 | 15-09-30 |
Barry Quart
BRD | Director/Board Member | 67 | 15-09-30 |
Thomas Malley
BRD | Director/Board Member | 55 | 16-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.03% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 19.58 | +0.26% | 193,968 |
24-05-10 | 19.53 | -3.27% | 333,361 |
24-05-09 | 20.19 | -0.35% | 344,706 |
24-05-08 | 20.26 | -0.34% | 272,503 |
24-05-07 | 20.33 | +1.70% | 332,862 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.63% | 1.39B | |
+5.66% | 111B | |
+11.23% | 105B | |
-0.38% | 21.93B | |
-12.15% | 22.34B | |
-7.66% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- KNSA Stock